Alina Franzen Selected Research

Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)

9/2014	Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
5/2014	A new bright-field dual-colour chromogenic and silver in situ hybridization method for the detection of FGFR1 gene copy number status.
10/2013	Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.
1/2013	Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.
10/2012	Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alina Franzen Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 10/2012
10	Squamous Cell Carcinoma of Head and Neck 01/2022 - 10/2013
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017 - 10/2013
3	Lung Neoplasms (Lung Cancer) 09/2014 - 10/2012
2	Infections 01/2022 - 10/2013
2	Papillomavirus Infections 01/2018 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 01/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2013 - 10/2012
2	Lymphatic Metastasis 01/2013 - 10/2012
1	Papillary Thyroid Cancer 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Carcinoma (Carcinomatosis) 01/2013

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2013
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2013
5	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2014 - 10/2012
4	Messenger RNA (mRNA)IBA 01/2022 - 10/2015
3	Long Noncoding RNAIBA 01/2020 - 11/2016
3	Formaldehyde (Formol)FDA Link 11/2016 - 10/2012
3	ParaffinIBA 11/2016 - 10/2012
2	N-acetyltalosaminuronic acid (NAT)IBA 01/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 11/2016
2	Cell-Free Nucleic AcidsIBA 07/2017 - 01/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2013 - 10/2012
1	InterferonsIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2018
1	SeptinsIBA 07/2017
1	homeobox protein PITX3IBA 01/2017
1	hydrogen sulfite (bisulfite)IBA 11/2016
1	Biological ProductsIBA 10/2016
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 10/2016
1	infigratinibIBA 10/2015
1	Tyrosine Kinase InhibitorsIBA 10/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2014
1	Nicotine FDA Link 10/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013

Therapy/Procedure

5	Therapeutics 07/2014 - 10/2012
1	Immunotherapy 01/2022
1	Adjuvant Chemoradiotherapy 11/2016
1	Chemoradiotherapy 11/2016
1	Combined Modality Therapy 09/2014